64
Participants
Start Date
March 1, 2023
Primary Completion Date
September 1, 2023
Study Completion Date
December 31, 2023
Neostigmine
a combination of 0.04 mg/kg neostigmine with 0.01 mg/kg atropine intravenously at the reappearance of a second twitch of TOF after the last dose of rocuronium
Sugammadex
2-4 mg/kg sugammadex intravenously upon the reappearance of a post-tetanic count 1-2 or a second twitch of TOF after the last dose of rocuronium
Menoufia University Hospitals, Shibīn al Kawm
Menoufia University
OTHER